JP2024535596A5 - - Google Patents

Info

Publication number
JP2024535596A5
JP2024535596A5 JP2024522260A JP2024522260A JP2024535596A5 JP 2024535596 A5 JP2024535596 A5 JP 2024535596A5 JP 2024522260 A JP2024522260 A JP 2024522260A JP 2024522260 A JP2024522260 A JP 2024522260A JP 2024535596 A5 JP2024535596 A5 JP 2024535596A5
Authority
JP
Japan
Application number
JP2024522260A
Other languages
Japanese (ja)
Other versions
JPWO2023062559A5 (https=
JP2024535596A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2022/059780 external-priority patent/WO2023062559A1/en
Publication of JP2024535596A publication Critical patent/JP2024535596A/ja
Publication of JP2024535596A5 publication Critical patent/JP2024535596A5/ja
Publication of JPWO2023062559A5 publication Critical patent/JPWO2023062559A5/ja
Pending legal-status Critical Current

Links

JP2024522260A 2021-10-13 2022-10-12 ヒト免疫不全ウイルス複製の阻害薬 Pending JP2024535596A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163255056P 2021-10-13 2021-10-13
US63/255,056 2021-10-13
US202163257212P 2021-10-19 2021-10-19
US63/257,212 2021-10-19
PCT/IB2022/059780 WO2023062559A1 (en) 2021-10-13 2022-10-12 Inhibitors of human immunodeficiency virus replication

Publications (3)

Publication Number Publication Date
JP2024535596A JP2024535596A (ja) 2024-09-30
JP2024535596A5 true JP2024535596A5 (https=) 2025-10-17
JPWO2023062559A5 JPWO2023062559A5 (https=) 2025-10-17

Family

ID=84044276

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024522260A Pending JP2024535596A (ja) 2021-10-13 2022-10-12 ヒト免疫不全ウイルス複製の阻害薬

Country Status (10)

Country Link
US (1) US20240423985A1 (https=)
EP (1) EP4415685A1 (https=)
JP (1) JP2024535596A (https=)
KR (1) KR20240074850A (https=)
AU (1) AU2022362855B2 (https=)
CA (1) CA3234219A1 (https=)
CL (1) CL2024001073A1 (https=)
IL (1) IL311982A (https=)
MX (1) MX2024004551A (https=)
WO (1) WO2023062559A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202128648A (zh) * 2019-10-04 2021-08-01 英商Viiv醫療保健英國(No 5)有限公司 人類免疫不全病毒複製之抑制劑
US12594276B2 (en) 2024-02-05 2026-04-07 Viiv Healthcare Uk (No. 5) Limited Inhibitors of human immunodeficiency virus replication

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230011471A (ko) * 2016-08-19 2023-01-20 길리애드 사이언시즈, 인코포레이티드 Hiv 바이러스 감염의 예방적 또는 치유적 치료에 유용한 치료 화합물
TWI687415B (zh) * 2017-08-17 2020-03-11 美商基利科學股份有限公司 Hiv蛋白質膜抑制劑之固體形式
CN120053445A (zh) * 2018-07-16 2025-05-30 吉利德科学公司 用于治疗hiv的衣壳抑制剂
MX2021004593A (es) * 2018-10-24 2021-06-15 Viiv Healthcare Uk No 5 Ltd Inhibidores de la replicacion del virus de la inmunodeficiencia humana.
LT3986561T (lt) * 2019-06-19 2024-04-25 VIIV Healthcare UK (No.5) Limited Pirido[2,3-d]pirimidino dariniai kaip žmogaus imunodeficito viruso replikacijos inhibitoriai
CN115397424A (zh) * 2020-04-15 2022-11-25 Viiv保健英国第五有限公司 人类免疫缺陷病毒复制的抑制剂

Similar Documents

Publication Publication Date Title
CL2025003844A1 (es) Molécula de arn diseñada genéticamente con expresión ajustable
JP2024535596A5 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
BY13165U (https=)
BY13169U (https=)
CN307046676S (https=)
CN307047137S (https=)
CN307045102S (https=)
CN307044610S (https=)
CN307044568S (https=)
CN307044414S (https=)
CN307048437S (https=)
BY23963C1 (https=)
BY13176U (https=)
BY13175U (https=)
BY13174U (https=)
BY13172U (https=)
BY13170U (https=)
BY13162U (https=)
BY13168U (https=)
BY13167U (https=)
BY13166U (https=)
BY13158U (https=)
BY13164U (https=)